CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway

Peng Liu(Sun Yat-sen University), Jian Dong(Anyang Hospital of Traditional Chinese Medicine)

International Journal of Oncology

July 18, 2018

10.3892/ijo.2018.4487

Cited by 60

Related Papers

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

|Journal of Hematology & Oncology|2017|256

NCAPH plays important roles in human colon cancer

|Cell Death and Disease|2017|90

CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway

|Journal of Cancer|2018|68

Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal

|Journal of Nanobiotechnology|2021|67

CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway

|Oncology Reports|2019|48